Red blood cells from patients with homozygous sickle cell disease provide a catalytic surface for factor Va inactivation by activated protein C

British Journal of Haematology

Volumn 117, Issue 2, 2002, Pages 409-413

  Bezeaud, Annie ^a,b   Venisse, Laurence ^a   Helley, Dominique ^a   Trichet, Catherine ^a   Girot, Robert ^c   Guillin, Marie Claude ^a,d  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

^c HÔPITAL TENON   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Activated protein C; Factor Va; Red blood cells; Sickle cell disease

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PROCOAGULANT; PROTEIN C;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; CATALYSIS; CELL ACTIVITY; CELL SURFACE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE STRUCTURE; FEMALE; HOMOZYGOTE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; VENOUS BLOOD;

EID: 0036252406     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03445.x     Document Type: Article

References (28)

1. Role of red blood cells in thrombosis
2. Heterogeneity in human prothrombin: Analysis of cause
3. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C
4. Enzymic and nonenzymic properties of human beta-thrombin
5. Prothrombin Salakta: An abnormal prothrombin characterized by a defect in the active site of thrombin
6. Transmembrane mobility of phospholipids in sickle erythrocytes: Effect of deoxygenation on diffusion and asymmetry
7. Regulation of blood coagulation
8. Human thrombins. Production, evaluation, and properties of alpha-thrombin
9. Bovine factor X, 1 (Stuart factor). Mechanism of activation by protein from Russell's viper venom
10. Molecular and cellular biology of blood coagulation
11. Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology
12. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia
13. Sickle cell disease: Relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation
14. Characterization of the phosphatidylserine-exposing subpopulation of sickle cells
15. Membrane-dependent reactions in blood coagulation: Role of the vitamin K-dependent enzyme complexes
16. Human protein C Isolation, characterization, and mechanism of activation by alpha-thrombin
17. Phospholipid asymmetry in health and disease
18. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V
19. Phospholipid composition and organization in model beta-thalassemic erythrocytes
20. Abnormalities in membrane phospholipid organization in sickled erythrocytes
21. Transbilayer movement of phospholipids in red cell and platelet membranes
22. Fetal hemoglobin in sickle cell disease: Relationship to erythrocyte phosphatidylserine exposure and coagulation activation
23. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C
24. Kinetics of inactivation of membrane-bound factor Va by APC. Protein S modulates factor Xa protection
25. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
26. Radioimmunoassay of factor V in human plasma and platelets
27. Kinetic studies of prothrombin activation: Effect of factor Va and phospholipids on the formation of the enzyme-substrate complex
28. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations